API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Use and Safety of Grepafloxacin

Grepafloxacin (OPC-17116) is a broad-spectrum fluoroquinolone with the chemical structure (+)-1-cyclopropyl-6-fluoro-1,4-dihydro-5- methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolone carboxylic acid

Mar 25,2022  API

Uses of Temafloxacin

Temafloxacin (6-fluoro-7-piperazino-4-quinolone)was discontinued in June 1992, only five months after gaining marketing approval. This was due to a high rate of reported adverse reactions, including s

Mar 25,2022  API

Uses of Fleroxacin

Fleroxacin (Ro 23-6240, AM 833) is different from fluoroquinolones such as ciprofloxacin or ofloxacin, since it is a trifluorinated quinolone, having three fluorine atoms rather than one attached to t

Mar 25,2022  API

Side effects of Tosufloxacin

Tosufloxacin was developed by Taisho-Toyama Chemistry (Ozexs) and became commercially available in 1990. It is a newer-generation oral fluoroquinolone with a broad spectrum of activity against Gramneg

Mar 25,2022  API

Imipenem: Antimicrobial Activity, Susceptibility, Administration and Dosage, Toxicity, Clinical Uses etc.

In the 1970s, Beecham Research Laboratories identified a carbapenem group, called olivanic acids, which were beta-lactamase inhibitors and broad-spectrum antibiotics (Butterworth et al., 1979).

Mar 25,2022  API

Side effects and Uses of Rufloxacin

Rufloxacin (MF 934), or 9-fluoro-10-(-methyl) piperazinyl-7-oxo-2,3- dihydro-7H-pyrido-(1,2,3, de) (1,4) benzothiazine-6-carboxylic acid, is an older-generation fluoroquinolone developed in 1989 with

Mar 25,2022  API

Side effects of Lomefloxacin

Lomefloxacin (Maxaquins, Pfizer) is an older-generation difluoroquinolone that has the chemical formula 1-ethyl-6,8-difluoro-1,4- dihydro-7-(3-methyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid. C

Mar 25,2022  API

Side effects of Sparfloxacin

Sparfloxacin (AT-4140, CI-978, PD 131501) is a newer-generation aminodifluoroquinolone with broad spectrum antibacterial activity. It has the chemical formula 5-amino-1-cyclopropyl-7-(cis-3,5-dimethyl

Mar 25,2022  API

Aztreonam: Antimicrobial Activity, Susceptibility, Administration and Dosage, Clinical Uses etc.

Aztreonam belongs to the class of beta-lactam antibiotics known as monobactams. Unlike penicillins and cephalosporins the monobactams have only the beta-lactam ring.

Mar 25,2022  API

Ceftobiprole: Antimicrobial Activity, Susceptibility, Administration and Dosage, Clinical Uses etc.

Ceftobiprole, formerly BAL9141 or Ro 63-9141, is a novel pyrrolidinone-3-ylidene-methyl cephalosporin with clinically demonstrable activity against methicillin-resistant Staphylococcus aureus (MRSA).

Mar 25,2022  API
Prev12345678910...Next>  Go to Page